Physician profile
Laith Derbas
NPI 1790131779
$12,133.31
in general payments reported to CMS, 2019-2025
26 companies · $4,104 in 2025
The $4,104 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $246 · 2021: $603 · 2022: $1,321 · 2023: $2,775 · 2024: $3,084 · 2025: $4,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,643 · Grant: $1,421 · Travel and Lodging: $848 · Education: $51.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,643.18 |
| Grant | $1,420.56 |
| Travel and Lodging | $848.07 |
| Education | $51.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,084.49 | 2022-2025 | Watchman Flx, Stingray, Watchman Access System |
| Medtronic, INC. | $2,121.19 | 2022-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abiomed | $1,577.26 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $1,346.65 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $1,055.08 | 2021-2025 | Mitraclip, Navitor, Aveir |
| Cardiovascular Systems INC. | $432.43 | 2021-2022 | |
| Inari Medical, INC. | $402.46 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $247.68 | 2023-2024 | Indigo System |
| Teleflex LLC | $216.63 | 2022-2025 | Turnpike |
| Philips North America LLC | $185.42 | 2023-2025 | Labosys, (Bq9) Coronary Ivus, Ecc Solutions |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.77 | 2020-2025 | Lifevest |
| Cardiac Dimensions, INC. | $130.26 | 2023 | |
| Novo Nordisk INC | $124.67 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $123.70 | 2020 | |
| Cordis US Corp. | $121.59 | 2022-2023 | Mynx Control |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $117.12 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $116.98 | 2021 | |
| Terumo Medical Corporation | $94.13 | 2022-2023 | Azur Cx Detachable, Angio-Seal |
| Novartis Pharmaceuticals Corporation | $84.19 | 2023-2025 | |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Janssen Pharmaceuticals, INC | $77.90 | 2022 | |
| Livanova USA, INC. | $71.09 | 2022 | |
| W. L. Gore & Associates, INC. | $50.00 | 2025 | Gore-Tex Vascular Graft |
| Acist Medical Systems, INC. | $44.48 | 2024 | |
| Opsens INC. | $38.72 | 2023 | Optowire |
| Pfizer INC. | $15.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laith Derbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.